A new study supports the use of a DNA-based “biomarker” blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer... Read more
A new study supports the use of a DNA-based “biomarker” blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer... Read more
Copyright 2021 Innovation Toronto